ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666038 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666038; 2) Community: the network communities that were significantly associated with the response to NSC 666038; 3) Molecule: the relationships between components within communities and NSC 666038; 4) MDR: the compounds that were significantly associated with the NSC 666038.

NSC Compound Enrichment Correlation
NSC 315844 2(1H)-Pyrimidinone, 1-(2,5-dihydro-5-oxo-2-furanyl)-5-fluoro-4-methoxy- 0.00714731931708452 0.57860659
NSC 632882 Dicarbonyl[1-(4-cyanaphenyl-NC-azomethyine)- naphthaline-2-olato(O1,N1)]iridium(I) 0.00714731931708452 0.58915892
NSC 671009 2H-Thieno[3',4':4,5]cyclopent[1,2-d]oxazole- 2,7(7aH)-dione,4,6-dibromo-3,3a-dihydro- 0.00714731931708452 0.70649699
NSC 678879 Null 0.00714731931708452 0.16569078
NSC 709361 Null 0.00714731931708452 0.64802016
NSC 711739 Null 0.00714731931708452 0.50124808
NSC 746687 (2E)-3-(2-phenyl-1H-indol-3-yl)-2-(phenylsulfonyl)acrylonitrile 0.00714731931708452 0.29909469
NSC 631542 Null 0.00770426557728501 0.50667145
NSC 654379 ANTINEOPLASTIC-654379 0.00770426557728501 0.64249547
NSC 679002 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl]-, diethyl ester, cis- 0.00770426557728506 0.76991707
Total:55  Current:9    [First] [Prev] [Next] [Last]